Actively Recruiting
Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
Led by Hoffmann-La Roche · Updated on 2026-05-05
800
Participants Needed
41
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a multicenter, prospective, cohort study designed to evaluate the clinical outcomes and characteristics of resected stage II-IIIB anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC) adult patients treated with Alectinib as adjuvant therapy in China.
CONDITIONS
Official Title
Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically-confirmed stage II-IIIA or selected IIIB (T3N2) non-small-cell lung cancer
- ALK-positive status confirmed
- Postoperative patients who have undergone complete tumor resection
- Patients treated with Alectinib monotherapy as adjuvant therapy without prior systemic treatment
- Time from first Alectinib dose to enrollment is no more than 28 days
You will not qualify if you...
- Participation in any interventional study of adjuvant treatment
- Pregnant, lactating, or breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 41 locations
1
Affiliated Hospital of Guangdong Medical University
Zhanjiang, Guangdong, China, 524001
Actively Recruiting
2
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Guangzhou, Guangzhou, China, 510095
Actively Recruiting
3
Huai He Hospital of Henan University
Kaifeng, Henan, China, 475001
Actively Recruiting
4
Henan Provincial Chest Hospital
Zhengzhou, Henan, China, 450003
Actively Recruiting
5
The First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China, 830054
Actively Recruiting
6
Peking University First Hospital
Beijing, China, 100034
Actively Recruiting
7
Xuanwu Hospital, Capital Medical University
Beijing, China, 100053
Active, Not Recruiting
8
Hunan Cancer Hospital
Changsha, China, 410013
Actively Recruiting
9
Changzhou First People's Hospital
Changzhou, China, 213003
Actively Recruiting
10
Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital
Chengdu, China, 610072
Actively Recruiting
11
The First Affiliated Hospital, Chongqing Medical University
Chongqing, China, 400016
Actively Recruiting
12
The Second Affiliated Hospital of Dalian Medical University
Dalian, China, 116027
Actively Recruiting
13
Fujian Cancer Hospital
Fuzhou, China, 350014
Actively Recruiting
14
The Third Affiliated Hospital of Sun Yat-Sen University
Guangzhou, China, 510630
Actively Recruiting
15
The Second Affiliated Hospital, Zhejiang University
Hangzhou, China, 310009
Actively Recruiting
16
Zhejiang Cancer Hospital
Hangzhou, China, 310022
Actively Recruiting
17
Harbin Medical University Cancer Hospital
Harbin, China, 150081
Actively Recruiting
18
Anhui Provincial Hospital
Hefei, China, 230001
Actively Recruiting
19
Huzhou Central Hospital
Huzhou, China, 313000
Actively Recruiting
20
Jiangmen Central Hospital
Jiangmen, China, 529030
Actively Recruiting
21
Shandong Provincial Hospital
Jinan, China, 250021
Actively Recruiting
22
Lanzhou University Second Hospital
Lanzhou, China, 730030
Actively Recruiting
23
The First Affiliated Hospital of Nanchang University
Nanchang, China
Actively Recruiting
24
Jiangsu Cancer Hospital
Nanjing, China, 210000
Actively Recruiting
25
Jiangsu Province Hospital
Nanjing, China, 210008
Actively Recruiting
26
Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School
Nanjing, China, 210008
Actively Recruiting
27
Affiliated Hospital of Nantong University
Nantong, China, 226001
Actively Recruiting
28
Ningbo No.2 Hospital
Ningbo, China, 315000
Actively Recruiting
29
Shanghai Chest Hospital
Shanghai, China, 200030
Actively Recruiting
30
Zhongshan Hospital Fudan University
Shanghai, China, 200032
Actively Recruiting
31
Shanghai Pulmonary Hospital
Shanghai, China, 200433
Actively Recruiting
32
Liaoning Provincial Cancer Hospital
Shengyang, China, 110042
Actively Recruiting
33
Hebei Medical University Fourth Hospital
Shijiazhuang, China, 50011
Actively Recruiting
34
Shanxi Provincial Cancer Hospital
Taiyuan, China, 030013
Actively Recruiting
35
Taizhou Hospital of Zhejiang Province
Taizhou, China, 317000
Actively Recruiting
36
Chest disease hospital of Tianjin City
Tianjin, China
Actively Recruiting
37
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
Wuhan, China, 430030
Actively Recruiting
38
Wuxi People's Hospital
Wuxi, China, 214023
Actively Recruiting
39
Xi'an International Medical Center Hospital
Xi'an, China, 710100
Actively Recruiting
40
General Hospital of Ningxia Medical University
Yinchuan, China, 750004
Actively Recruiting
41
Affiliated Hospital of Zunyi Medical University
Zunyi, China, 563000
Actively Recruiting
Research Team
R
Reference Study ID Number: ML45766 https://forpatients.roche.com/
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here